NCT07093580 - Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 29, 2025

Primary Completion Date

May 26, 2027

Study Completion Date

May 26, 2027

Conditions

Healthy Participants

Interventions

DRUG

S-892216-LAI

S-892216-LAI injection will be administered per schedule specified in the arm description.

DRUG

Placebo

Physiological saline will be administered per schedule specified in the arm description.

Trial Locations (2)

RECRUITING

ICON Clinical Research: Lenexa, Lenexa

RECRUITING

ICON Clinical Research: Salt Lake City, Salt Lake City